• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chemoenzymatic site-specific labeling of influenza glycoproteins as a tool to observe virus budding in real time

tetano

Editor, Senior Moderator
PLoS Pathog. 2012 Mar;8(3):e1002604. Epub 2012 Mar 22.
Chemoenzymatic site-specific labeling of influenza glycoproteins as a tool to observe virus budding in real time.
Popp MW, Karssemeijer RA, Ploegh HL.
Source

Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, United States of America.
Abstract

The influenza virus uses the hemagglutinin (HA) and neuraminidase (NA) glycoproteins to interact with and infect host cells. While biochemical and microscopic methods allow examination of the early steps in flu infection, the genesis of progeny virions has been more difficult to follow, mainly because of difficulties inherent in fluorescent labeling of flu proteins in a manner compatible with live cell imaging. We here apply sortagging as a chemoenzymatic approach to label genetically modified but infectious flu and track the flu glycoproteins during the course of infection. This method cleanly distinguishes influenza glycoproteins from host glycoproteins and so can be used to assess the behavior of HA or NA biochemically and to observe the flu glycoproteins directly by live cell imaging.

PMID:
22457626
[PubMed - in process]
PMCID:
PMC3310791

http://www.ncbi.nlm.nih.gov/pubmed/22457626
 
Back
Top Bottom